聽力損失疾病治療市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Hearing Loss Disease Treatment Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月07日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在聽力損失盛行率不斷上升、意識提高和政府支持措施的推動下，全球聽力損失疾病治療市場在 2024 年至 2032 年間將以 5.4% 的複合年成長率成長。隨著全球人口老化，聽力障礙的發生率不斷上升，對助聽器、人工耳蝸和藥物等治療方案的需求不斷增加。公共衛生運動正在提高人們對早期診斷和可用治療的認知，而政府正在實施政策和資助措施以提高可及性，從而在未來幾年進一步擴大市場規模。

聽力損失疾病治療行業根據治療類型、狀況、最終用途和地區進行分類。

在助聽器、人工耳蝸和骨錨式聽力系統廣泛採用的推動下，設備細分市場在 2023 年累計達到 97 億美元。這些設備為不同程度的聽力障礙提供了有效的解決方案，使其備受追捧。無線連接和聲音放大等不斷的技術進步增強了用戶體驗，推動了需求。此外，透過政府支持和保險覆蓋範圍增加可及性進一步促進了設備細分市場的成長，鞏固了其在市場上的主導地位。

由於感音神經性聽力損失的高盛行率和對有效治療的需求，到 2032 年，感音神經性聽力損失市場將達到 125 億美元。感音神經性聽力損失通常是由內耳或聽覺神經損傷引起的，在老年人群和暴露於大聲噪音的個體中更為常見。人工耳蝸和助聽器等先進療法被廣泛用於治療這種疾病，推動市場成長。增加對治療方案的研究也支持了該領域的領先地位。

2023年，北美聽力損失疾病治療市場規模達到53億美元，在該地區先進的醫療基礎設施、聽力損失的高患病率以及創新治療技術的早期採用的推動下，到2032年複合年成長率將達到4.8%。人口老化和廣泛的宣傳活動進一步增加了對助聽器、人工耳蝸和其他療法的需求。此外，強而有力的政府支持和有利的報銷政策也有助於市場成長。美國憑藉其強大的研究計劃和高額的醫療保健支出，是這一地區主導地位的重要貢獻者。

產業生態系統分析
產業影響力
- 成長動力
  - 周邊動脈疾病（PAD）盛行率增加
  - 聽力損失盛行率上升
  - 技術進步
  - 提高認知和診斷
  - 政府支持舉措
- 產業陷阱與挑戰
  - 設備和治療費用高
  - 缺乏有關聽力損失的知識
成長潛力分析
技術景觀
未來市場趨勢
監管環境
產品管道分析
報銷場景
波特的分析
PESTEL分析
差距分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按治療類型，2021 - 2032 年

主要趨勢
裝置
- 助聽器
  - 耳背式 (BTE)
  - 耳內接收器/耳道接收器 (RITE/RIC)
  - 完全在根管內/隱形在根管內 (CIC/IIC)
  - 入耳式 (ITE)
  - 運河內 (ITC)
- 人工耳蝸
  - 單側植體
  - 雙側植體
- 骨錨式助聽器 (BAHA)
- 梅伊
藥品
- 全身類固醇
- 抗病毒藥物
- 血管擴張劑
- 其他藥品

第 6 章：市場估計與預測：按條件分類，2021 - 2032 年

主要趨勢
感音神經性聽損
傳導性聽力損失
混合性聽力損失

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
耳科診所
門診手術中心

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Bayer
Cochlear Ltd
Demant A/S
Eargo, Inc
GlaxoSmithKline
GN Store Nord A/S
Pfizer
Sonova Holding AG
Starkey
WS Audiology

簡介目錄

Product Code: 10708

The Global Hearing Loss Disease Treatment Market will grow at a 5.4% CAGR between 2024 and 2032, driven by the increasing prevalence of hearing loss, greater awareness, and supportive government initiatives. As the global population ages, the incidence of hearing impairments is rising, creating higher demand for treatment options such as hearing aids, cochlear implants, and medications. Public health campaigns are raising awareness about early diagnosis and available treatments, while governments are implementing policies and funding initiatives to improve accessibility, further expanding the market size in the coming years.

The hearing loss disease treatment industry is divided based on treatment type, condition, end-use, and region.

The devices segment accumulated USD 9.7 billion in 2023, fueled by the widespread adoption of hearing aids, cochlear implants, and bone-anchored hearing systems. These devices offer effective solutions for various degrees of hearing impairment, making them highly sought-after. Continuous technological advancements, including wireless connectivity and sound amplification, enhance the user experience, driving demand. Additionally, increasing accessibility through government support and insurance coverage has further boosted the growth of the devices segment, solidifying its dominance in the market.

The sensorineural hearing loss segment will capture USD 12.5 billion by 2032 due to its high prevalence and the need for effective treatments. Sensorineural hearing loss, often caused by damage to the inner ear or auditory nerves, is more common among aging populations and individuals exposed to loud noise. Advanced therapies such as cochlear implants and hearing aids are widely used to manage this condition, driving market growth. Increasing research into treatment options also supports the segment's leading position.

In 2023, the North America hearing loss disease treatment market recorded USD 5.3 billion and will reach a 4.8% CAGR through 2032, spurred by the region's advanced healthcare infrastructure, high prevalence of hearing loss, and early adoption of innovative treatment technologies. The aging population and widespread awareness campaigns further boost demand for hearing aids, cochlear implants, and other therapies. Additionally, strong government support and favorable reimbursement policies contribute to market growth. The United States, with its robust research initiatives and high healthcare spending, is a significant contributor to this regional dominance.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of peripheral artery disease (PAD)
  - 3.2.1.2 Rising prevalence of hearing loss
  - 3.2.1.3 Technological advancements
  - 3.2.1.4 Increased awareness and diagnosis
  - 3.2.1.5 Supportive government initiatives
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of devices and treatment
  - 3.2.2.2 Lack of knowledge regarding hearing loss
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Future market trends
3.6 Regulatory landscape
3.7 Product pipeline analysis
3.8 Reimbursement scenario
3.9 Porter's analysis
3.10 PESTEL analysis
3.11 Gap analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Devices
- 5.2.1 Hearing aids
  - 5.2.1.1 Behind-the-ear (BTE)
  - 5.2.1.2 Receiver in the ear/receiver in canal (RITE/RIC)
  - 5.2.1.3 Completely-in-the-canal/invisible-in-canal (CIC/IIC)
  - 5.2.1.4 In-the-ear (ITE)
  - 5.2.1.5 In-the-canal (ITC)
- 5.2.2 Cochlear implants
  - 5.2.2.1 Unilateral implants
  - 5.2.2.2 Bilateral implants
- 5.2.3 Bone-anchored hearing aids (BAHA)
- 5.2.4 MEI
5.3 Drugs
- 5.3.1 Systemic steroids
- 5.3.2 Antiviral medication
- 5.3.3 Vasodilators
- 5.3.4 Other drugs

Chapter 6 Market Estimates and Forecast, By Condition, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Sensorineural hearing loss
6.3 Conductive hearing loss
6.4 Mixed hearing loss

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Otology clinics
7.4 Ambulatory surgical centers

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa